September 16, 2022

We’ve had TransMedics (TMDX) for just two months and the stock has traded up 45% - 50% in that time frame, with very little volatility.

TransMedics (TMDX): Sell a Few Shares

We’ve had TransMedics (TMDX) for just two months and the stock has traded up 45% - 50% in that time frame, with very little volatility. Except for today. Shares are off 6% and are modestly below recent support at 50. This is far from being a disaster day for the stock but all the same, I suggest taking a partial profit (i.e., sell a small portion of your position) just in case the market takes a turn for the worse and the high-flyers (like TMDX) get dragged into the mud. For record-keeping purposes, I’m recording this as a one-quarter position sale. SELL A QUARTER

Tyler Laundon

Tyler Laundon is chief analyst of the limited-subscription advisory, Cabot Small-Cap Confidential and grand slam advisory Cabot Early Opportunities. He has spent his entire career managing, consulting and analyzing start-up and small-cap companies. His hands-on experience has taught Tyler that the development of a superior business model is the biggest factor in determining a company’s long-term success. Accordingly, his research focuses on assessing the viability of management’s growth strategies, trends in addressable markets and achievement of major developmental milestones.

September 16, 2022

We’ve had TransMedics (TMDX) for just two months and the stock has traded up 45% - 50% in that time frame, with very little volatility.